<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">26067</article-id><article-id pub-id-type="doi">10.7554/eLife.26067</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Structure and topology around the cleavage site regulate post-translational cleavage of the HIV-1 gp160 signal peptide</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-84780"><name><surname>Snapp</surname><given-names>Erik Lee</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-81599"><name><surname>McCaul</surname><given-names>Nicholas</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7888-7815</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-84781"><name><surname>Quandte</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-84801"><name><surname>Cabartova</surname><given-names>Zuzana</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-84786"><name><surname>Bontjer</surname><given-names>Ilja</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-84813"><name><surname>Källgren</surname><given-names>Carolina</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-84789"><name><surname>Nilsson</surname><given-names>IngMarie</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-84791"><name><surname>Land</surname><given-names>Aafke</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81090"><name><surname>von Heijne</surname><given-names>Gunnar</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4490-8569</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-84790"><name><surname>Sanders</surname><given-names>Rogier W</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-42702"><name><surname>Braakman</surname><given-names>Ineke</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1592-4364</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>Janelia Research Campus</institution>, <addr-line><named-content content-type="city">Ashburn</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Cellular Protein Chemistry</institution>, <institution>Utrecht University</institution>, <addr-line><named-content content-type="city">Utrecht</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff3"><institution>dr heinekamp Benelux B.V.</institution>, <addr-line><named-content content-type="city">Riethoven</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff4"><institution content-type="dept">National Reference Laboratory for Viral Hepatitis</institution>, <institution>National Institute of Public Health</institution>, <addr-line><named-content content-type="city">Šrobárova</named-content></addr-line>, <country>Czech Republic</country></aff><aff id="aff5"><institution content-type="dept">Department of Medical Microbiology</institution>, <institution>Academic Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff6"><institution content-type="dept">Department of Biochemistry and Biophysics</institution>, <institution>Stockholm University</institution>, <addr-line><named-content content-type="city">Stockholm</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff7"><institution content-type="dept">Department of Biochemistry and Biophysics</institution>, <institution>Stockholm Unversity</institution>, <addr-line><named-content content-type="city">Stockholm</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff8"><institution content-type="dept">Hogeschool Utrecht</institution>, <institution>Institute of Life Sciences</institution>, <addr-line><named-content content-type="city">Utrecht</named-content></addr-line>, <country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-7744"><name><surname>Gilmore</surname><given-names>Reid</given-names></name><role>Reviewing editor</role><aff><institution>University of Massachusetts Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>i.braakman@uu.nl</email> (IB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>07</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e26067</elocation-id><history><date date-type="received"><day>27</day><month>02</month><year>2017</year></date><date date-type="accepted"><day>26</day><month>07</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Snapp et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Snapp et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-26067-v1.pdf"/><abstract><p>Like all other secretory proteins, the HIV-1 envelope glycoprotein gp160, is targeted to the endoplasmic reticulum (ER) by its signal peptide during synthesis. Proper gp160 folding in the ER requires core glycosylation, disulfide-bond formation and proline isomerization. Signal-peptide cleavage occurs only late after gp160 chain termination and is dependent on folding of the soluble subunit gp120 to a near-native conformation. We here detail the mechanism by which co-translational signal-peptide cleavage is prevented. Conserved residues from the signal peptide and residues downstream of the canonical cleavage site form an extended alpha-helix in the ER membrane that covers the cleavage site, thus preventing cleavage. A point mutation in the signal peptide breaks the alpha helix allowing co-translational cleavage. We demonstrate that postponed cleavage of gp160 enhances functional folding of the molecule. The change to early cleavage results in decreased viral fitness compared to wild-type HIV.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003246</institution-id><institution>Nederlandse Organisatie voor Wetenschappelijk Onderzoek</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>McCaul</surname><given-names>Nicholas</given-names></name><name><surname>Quandte</surname><given-names>Matthias</given-names></name><name><surname>Land</surname><given-names>Aafke</given-names></name><name><surname>Braakman</surname><given-names>Ineke</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Netherlands AIDS Fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Land</surname><given-names>Aafke</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004963</institution-id><institution>Seventh Framework Programme</institution></institution-wrap></funding-source><award-id>ITN 'Virus Entry'</award-id><principal-award-recipient><name><surname>McCaul</surname><given-names>Nicholas</given-names></name><name><surname>Quandte</surname><given-names>Matthias</given-names></name><name><surname>Braakman</surname><given-names>Ineke</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NIH AI-51519</award-id><principal-award-recipient><name><surname>Snapp</surname><given-names>Erik Lee</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Swedish Cancer Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Nilsson</surname><given-names>IngMarie</given-names></name><name><surname>von Heijne</surname><given-names>Gunnar</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Knut and Alice Wallenberg Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>von Heijne</surname><given-names>Gunnar</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>European Research Council</institution></institution-wrap></funding-source><award-id>ERC-StG-2011-280829-SHEV</award-id><principal-award-recipient><name><surname>Sanders</surname><given-names>Rogier W</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Erik Lee Snapp, Has filed a patent application with and licensed technology to Lucigen Corp (U.S. Patent Application 15/152/908). The technology is not related to this manuscript..</p></fn><fn fn-type="conflict" id="conf3"><p>Rogier W Sanders, Is listed as an inventor on patents involving recombinant, soluble native-like Env trimers (EP2975053A1, EP2765138A3, WO/2017/055522A1, WO/2011/108937, WO/2010/041942, WO/2008/103428A2, WO/2003/022869A2). The technology is not related to this manuscript..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-26067-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>